Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel isoindolone-based antitumor compound synthesis via patent CN119874717B. Mild conditions, high yield. Reliable pharmaceutical intermediate supplier for scale-up.
Patent CN111978265B details a cost-effective FeCl3-catalyzed route for 5-trifluoromethyl-1,2,4-triazoles, offering significant supply chain advantages for API manufacturers.
Patent CN115385916B details a novel chiral phosphoric acid catalyzed route offering high enantioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN121378226A reveals a mild synthesis method for oxindole compounds with high yield. This offers cost reduction and supply reliability for pharmaceutical intermediates.
Novel reductive amination route for bromhexine hydrochloride offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Novel acid-catalyzed cyclization for fused biindoles. Mild conditions, high purity, scalable process for pharmaceutical intermediates and drug discovery.
Patent CN114456089B details a novel cobalt-catalyzed three-component reaction enabling efficient synthesis of amino-nitrile pharmaceutical intermediates with reduced costs.
Novel AlCl3-catalyzed route offers high stereoselectivity and mild conditions for scalable production of key pharmaceutical intermediates.
Discover the novel Sc(OTf)3-catalyzed synthesis of indole-derived piperidines. A cost-effective, high-yield route for anticancer pharmaceutical intermediates with superior diastereoselectivity.
Patent CN102464613A reveals a mild, high-yield quinoline synthesis using Lewis acids and oxidants. Ideal for reliable pharmaceutical intermediate suppliers seeking cost reduction.
Patent CN111848322B reveals a novel resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for reliable pharmaceutical intermediate supply chains.
Patent CN118878452B reveals mild synthesis for antitumor intermediates. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel trifluoromethanesulfonic acid catalyzed method for dihydroquinolinopyrrole derivatives offering mild conditions and high selectivity for pharmaceutical supply chains.
Novel patent CN116768904B enables high-purity intermediate production with mild conditions and substantial supply chain efficiency improvements for global pharmaceutical manufacturing partners seeking reliable sourcing.
Patent CN113735867B reveals mild chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates with significant cost and supply chain advantages.
Novel chiral phosphoric acid catalysis enables high-purity indoline pyrroles. Efficient synthesis reduces costs for anticancer pharmaceutical intermediates supply chains.
Patent CN107021866A details a Lewis acid catalyzed route for chain enyne compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with scalable supply chain reliability and cost efficiency.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Novel AlCl3-catalyzed route offers high Z-selectivity and mild conditions for scalable phthalide intermediate manufacturing.